SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 52 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,542 | +55.3% | 36,592 | +100.3% | 0.00% | – |
| Q4 2022 | $16,443 | -85.2% | 18,271 | -1.2% | 0.00% | – |
| Q3 2022 | $111,000 | +484.2% | 18,495 | +330.4% | 0.00% | – |
| Q4 2021 | $19,000 | +46.2% | 4,297 | +125.8% | 0.00% | – |
| Q2 2021 | $13,000 | -71.7% | 1,903 | -75.7% | 0.00% | – |
| Q1 2021 | $46,000 | +155.6% | 7,835 | +96.3% | 0.00% | – |
| Q4 2020 | $18,000 | +50.0% | 3,992 | +29.4% | 0.00% | – |
| Q3 2020 | $12,000 | -93.3% | 3,084 | -50.3% | 0.00% | – |
| Q2 2020 | $179,000 | +126.6% | 6,209 | +68.8% | 0.00% | – |
| Q1 2020 | $79,000 | +464.3% | 3,679 | +424.8% | 0.00% | – |
| Q4 2019 | $14,000 | – | 701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |